Programmed drug delivery: nanosystems for tumor targeting

Bibliography

• MAEDA H: The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. (2001) 41:189-207.
   PubMedGoogle Scholar
• DUNCAN R: The dawning era of polymer therapeutics. Nat. Rev. Drug Discov. (2003) 2:347-360.
   PubMed Web of Science ®Google Scholar
• ALLEN TM, CULLIS PR: Drug delivery systems: entering the mainstream. Science (2004) 303:1818-1822.
   PubMed Web of Science ®Google Scholar
• GABIZON AA, SHMEEDA H, ZALIPSKY S: Pros and cons of the liposome platform in cancer drug targeting. J. Liposome Res. (2006) 16:175-183.
   PubMed Web of Science ®Google Scholar
• GOREN D, HOROWITZ AT, ZALIPSKY S, WOODLE MC, YARDEN Y, GABIZON A: Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies. Br. J. Cancer (1996) 74:1749-1756.
   PubMed Web of Science ®Google Scholar
• UNEZAKI S, MARUYAMA K, HOSODA J et al.: Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy. Int. J. Pharm. (1996) 144(1):11-17.
   Web of Science ®Google Scholar
• TEN HAGEN TL, VAN DER VEEN AH, NOOIJEN PT, VAN TIEL ST, SEYNHAEVE AL, EGGERMONT AM: Low-dose tumor necrosis factor-alpha augments antitumor activity of stealth liposomal doxorubicin (DOXIL) in soft tissue sarcoma-bearing rats. Int. J. Cancer (2000) 87:829-837.
   PubMed Web of Science ®Google Scholar
• VAN HENSBERGEN Y, BROXTERMAN HJ, ELDERKAMP YW et al.: A doxorubicin-CNGRC-peptide conjugate with prodrug properties. Biochem. Pharmacol. (2002) 63:897-908.
   PubMed Web of Science ®Google Scholar
• TOMLINSON R, HELLER J, BROCCHINI S, DUNCAN R: Polyacetal-doxorubicin conjugates designed for pH-dependent degradation. Bioconjug. Chem. (2003) 14:1096-1106.
   PubMed Web of Science ®Google Scholar
• VIGLIANTI BL, PONCE AM, MICHELICH CR et al.: Chemodosimetry of in vivo tumor liposomal drug concentration using MRI. Magn. Reson. Med. (2006) 56:1011-1018.
   PubMed Web of Science ®Google Scholar
• DINSMORE AD, HSU MF, NIKOLAIDES MG, MARQUEZ M, BAUSCH AR, WEITZ DA: Colloidosomes: selectively permeable capsules composed of colloidal particles. Science (2002) 298:1006-1009.
   PubMed Web of Science ®Google Scholar
• HYUK IS, JEONG U, XIA Y: Polymer hollow particles with controllable holes in their surfaces. Nat. Mater. (2005) 4:671-675.
   PubMed Web of Science ®Google Scholar
• DUAN H, WANG D, SOBAL NS, GIERSIG M, KURTH DG, MOHWALD H: Magnetic colloidosomes derived from nanoparticle interfacial self-assembly. Nano Lett. (2005) 5:949-952.
   PubMed Web of Science ®Google Scholar
• SUKHORUKOV GB, MOHWALD H: Multifunctional cargo systems for biotechnology. Trends Biotechnol. (2007) 25(3):93-98.
   PubMed Web of Science ®Google Scholar
• ROY I, OHULCHANSKYY TY, BHARALI DJ et al.: Optical tracking of organically modified silica nanoparticles as DNA carriers: a nonviral, nanomedicine approach for gene delivery. Proc. Natl. Acad. Sci. USA (2005) 102:279-284.
   PubMed Web of Science ®Google Scholar
• WAGNER E: Strategies to improve DNA polyplexes for in vivo gene transfer: will ‘artificial viruses’ be the answer? Pharm. Res. (2004) 21:8-14.
   PubMed Web of Science ®Google Scholar
• AIGNER A: Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. J. Biotechnol. (2006) 124:12-25.
   PubMed Web of Science ®Google Scholar
• MEYER M, WAGNER E: Recent developments in the application of plasmid DNA-based vectors and small interfering RNA therapeutics for cancer. Hum. Gene Ther. (2006) 17:1062-1076.
   PubMed Web of Science ®Google Scholar
• FELGNER PL, BARENHOLZ Y, BEHR JP et al.: Nomenclature for synthetic gene delivery systems. Hum. Gene Ther. (1997) 8:511-512.
   PubMed Web of Science ®Google Scholar
• OUPICKY D, DIWADKAR V: Stimuli-responsive gene delivery vectors. Curr. Opin. Mol. Ther. (2003) 5:345-350.
   PubMed Web of Science ®Google Scholar
• BOECKLE S, WAGNER E. Optimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systems. AAPS J. (2006) 8(4):E731-E742.
   PubMed Web of Science ®Google Scholar
• KURSA M, WALKER GF, ROESSLER V et al.: Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Bioconjug. Chem. (2003) 14:222-231.
   PubMed Web of Science ®Google Scholar
• AMBEGIA E, ANSELL S, CULLIS P, HEYES J, PALMER L, MACLACHLAN I: Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression. Biochim. Biophys. Acta (2005) 1669:155-163.
   PubMed Web of Science ®Google Scholar
• MEYER M, WAGNER E: pH-responsive shielding of non-viral gene vectors. Expert. Opin. Drug Deliv. (2006) 3:563-571.
   PubMedGoogle Scholar
• GUO X, SZOKA FC JR: Chemical approaches to triggerable lipid vesicles for drug and gene delivery. Acc. Chem. Res. (2003) 36:335-341.
   PubMed Web of Science ®Google Scholar
• MASSON C, GARINOT M, MIGNET N et al.: pH-sensitive PEG lipids containing orthoester linkers: new potential tools for nonviral gene delivery. J. Control. Release (2004) 99:423-434.
   PubMed Web of Science ®Google Scholar
• LI W, HUANG Z, MACKAY JA, GRUBE S, SZOKA FC JR: Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery. J. Gene Med. (2005) 7:67-79.
   PubMed Web of Science ®Google Scholar
• MURTHY N, CAMPBELL J, FAUSTO N, HOFFMAN AS, STAYTON PS: Design and synthesis of pH-responsive polymeric carriers that target uptake and enhance the intracellular delivery of oligonucleotides. J. Control. Release (2003) 89:365-374.
   PubMed Web of Science ®Google Scholar
• MURTHY N, CAMPBELL J, FAUSTO N, HOFFMAN AS, STAYTON PS: Bioinspired pH-responsive polymers for the intracellular delivery of biomolecular drugs. Bioconjug. Chem. (2003) 14:412-419.
   PubMed Web of Science ®Google Scholar
• WALKER GF, FELLA C, PELISEK J et al.: Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo. Mol. Ther. (2005) 11:418-425.
   PubMed Web of Science ®Google Scholar
• OISHI M, NAGATSUGI F, SASAKI S, NAGASAKI Y, KATAOKA K: Smart polyion complex micelles for targeted intracellular delivery of PEGylated antisense oligonucleotides containing acid-labile linkages. Chembiochem. (2005) 6:718-725.
   PubMed Web of Science ®Google Scholar
• OISHI M, SASAKI S, NAGASAKI Y, KATAOKA K: pH-responsive oligodeoxynucleotide (ODN)-poly(ethylene glycol) conjugate through acid-labile beta-thiopropionate linkage: preparation and polyion complex micelle formation. Biomacromolecules (2003) 4:1426-1432.
   PubMed Web of Science ®Google Scholar
• SHIN J, SHUM P, THOMPSON DH: Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids. J. Control. Release (2003) 91:187-200.
   PubMed Web of Science ®Google Scholar
• AISSAOUI A, MARTIN B, KAN E et al.: Novel cationic lipids incorporating an acid-sensitive acylhydrazone linker: synthesis and transfection properties. J. Med. Chem. (2004) 47:5210-5223.
   PubMed Web of Science ®Google Scholar
• KIM YH, PARK JH, LEE M, KIM YH, PARK TG, KIM SW: Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. J. Control. Release (2005) 103:209-219.
   PubMed Web of Science ®Google Scholar
• HATAKEYAMA H, AKITA H, KOGURE K et al.: Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid. Gene Ther. (2007) 14:68-77.
   PubMed Web of Science ®Google Scholar
• GILLIES ER, GOODWIN AP, FRECHET JM: Acetals as pH-sensitive linkages for drug delivery. Bioconjug. Chem. (2004) 15:1254-1263.
   PubMed Web of Science ®Google Scholar
• GREENFIELD RS, KANEKO T, DAUES A et al.: Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker. Cancer Res. (1990) 50:6600-6607.
   PubMed Web of Science ®Google Scholar
• WAGNER E, PLANK C, ZATLOUKAL K, COTTEN M, BIRNSTIEL ML: Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc. Natl. Acad. Sci. USA (1992) 89:7934-7938.
   PubMed Web of Science ®Google Scholar
• PLANK C, OBERHAUSER B, MECHTLER K, KOCH C, WAGNER E: The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem. (1994) 269:12918-12924.
   Google Scholar
• ROZEMA DB, EKENA K, LEWIS DL, LOOMIS AG, WOLFF JA: Endosomolysis by masking of a membrane-active agent (EMMA) for cytoplasmic release of macromolecules. Bioconjug. Chem. (2003) 14:51-57.
   PubMed Web of Science ®Google Scholar
• SAITO G, SWANSON JA, LEE KD: Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv. Drug Deliv. Rev. (2003) 55:199-215.
   PubMed Web of Science ®Google Scholar
• SAITO G, AMIDON GL, LEE KD: Enhanced cytosolic delivery of plasmid DNA by a sulfhydryl-activatable listeriolysin O/protamine conjugate utilizing cellular reducing potential. Gene Ther. (2003) 10:72-83.
   PubMed Web of Science ®Google Scholar
• CHEN CP, KIM JS, STEENBLOCK E, LIU D, RICE KG: Gene transfer with poly-melittin peptides. Bioconjug. Chem. (2006) 17:1057-1062.
   PubMed Web of Science ®Google Scholar
• READ ML, BREMNER KH, OUPICKY D, GREEN NK, SEARLE PF, SEYMOUR LW: Vectors based on reducible polycations facilitate intracellular release of nucleic acids. J. Gene Med. (2003) 5:232-245.
   PubMed Web of Science ®Google Scholar
• READ ML, SINGH S, AHMED Z et al.: A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids. Nucleic Acids Res. (2005) 33:e86.
   PubMed Web of Science ®Google Scholar
• CARLISLE RC, ETRYCH T, BRIGGS SS, PREECE JA, ULBRICH K, SEYMOUR LW: Polymer-coated polyethylenimine/DNA complexes designed for triggered activation by intracellular reduction. J. Gene Med. (2004) 6:337-344.
   PubMed Web of Science ®Google Scholar
• GOTHELF A, MIR LM, GEHL J: Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat. Rev. (2003) 29:371-387.
   PubMed Web of Science ®Google Scholar
• SODEN DM, LARKIN JO, COLLINS CG et al.: Successful application of targeted electrochemotherapy using novel flexible electrodes and low dose bleomycin to solid tumours. Cancer Lett. (2006) 232:300-310.
   PubMed Web of Science ®Google Scholar
• AIHARA H, MIYAZAKI J: Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. (1998) 16:867-870.
   PubMed Web of Science ®Google Scholar
• MATHIESEN I: Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther. (1999) 6:508-514.
   PubMed Web of Science ®Google Scholar
• ZHANG L, NOLAN E, KREITSCHITZ S, RABUSSAY DP: Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation. Biochim. Biophys. Acta (2002) 1572:1-9.
   PubMed Web of Science ®Google Scholar
• HELLER L, JAROSZESKI MJ, COPPOLA D, POTTINGER C, GILBERT R, HELLER R: Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo. Gene Ther. (2000) 7:826-829.
   PubMed Web of Science ®Google Scholar
• GOTO T, NISHI T, TAMURA T et al.: Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA (2000) 97:354-359.
   PubMed Web of Science ®Google Scholar
• LUCAS ML, HELLER L, COPPOLA D, HELLER R: IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. Mol. Ther. (2002) 5:668-675.
   PubMed Web of Science ®Google Scholar
• HELLER LC, HELLER R: In vivo electroporation for gene therapy. Hum. Gene Ther. (2006) 17:890-897.
   PubMed Web of Science ®Google Scholar
• HUBER PE, PFISTERER P: In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound. Gene Ther. (2000) 7:1516-1525.
   PubMed Web of Science ®Google Scholar
• MANOME Y, NAKAMURA M, OHNO T, FURUHATA H: Ultrasound facilitates transduction of naked plasmid DNA into colon carcinoma cells in vitro and in vivo. Hum. Gene Ther. (2000) 11:1521-1528.
   PubMed Web of Science ®Google Scholar
• ANWER K, KAO G, PROCTOR B et al.: Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Ther. (2000) 7:1833-1839.
   PubMed Web of Science ®Google Scholar
• UNGER EC, MATSUNAGA TO, MCCREERY T, SCHUMANN P, SWEITZER R, QUIGLEY R: Therapeutic applications of microbubbles. Eur. J. Radiol. (2002) 42:160-168.
   PubMed Web of Science ®Google Scholar
• FRENKEL PA, CHEN S, THAI T, SHOHET RV, GRAYBURN PA: DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med. Biol. (2002) 28:817-822.
   PubMed Web of Science ®Google Scholar
• LI T, TACHIBANA K, KUROKI M, KUROKI M: Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice-initial results. Radiology (2003) 229:423-428.
   PubMed Web of Science ®Google Scholar
• HAUFF P, SEEMANN S, RESZKA R et al.: Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models. Radiology (2005) 236:572-578.
   PubMed Web of Science ®Google Scholar
• SEEMANN S, HAUFF P, SCHULTZE-MOSGAU M, LEHMANN C, RESZKA R: Pharmaceutical evaluation of gas-filled microparticles as gene delivery system. Pharm. Res. (2002) 19:250-257.
   PubMed Web of Science ®Google Scholar
• HUTH S, LAUSIER J, GERSTING SW et al.: Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J. Gene Med. (2004) 6:923-936.
   PubMed Web of Science ®Google Scholar
• SCHERER F, ANTON M, SCHILLINGER U et al.: Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. (2002) 9:102-109.
   PubMed Web of Science ®Google Scholar
• XENARIOU S, GRIESENBACH U, FERRARI S et al.: Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo. Gene Ther. (2006) 13:1545-1552.
   PubMed Web of Science ®Google Scholar
• SCHLEMMER M, LINDNER LH, ABDEL-RAHMAN S, ISSELS RD: [Principles, technology and indication of hyperthermia and part body hyperthermia]. Radiologe (2004) 44:301-309.
   PubMed Web of Science ®Google Scholar
• KONG G, ANYARAMBHATLA G, PETROS WP et al.: Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res. (2000) 60:6950-6957.
   PubMed Web of Science ®Google Scholar
• LINDNER LH, EICHHORN ME, EIBL H et al.: Novel temperature-sensitive liposomes with prolonged circulation time. Clin. Cancer Res. (2004) 10:2168-2178.
   PubMed Web of Science ®Google Scholar
• GABER MH, WU NZ, HONG K, HUANG SK, DEWHIRST MW, PAPAHADJOPOULOS D: Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. Int. J. Radiat. Oncol. Biol. Phys. (1996) 36:1177-1187.
   PubMed Web of Science ®Google Scholar
• CHANG E, CHALIKONDA S, FRIEDL J et al.: Targeting vaccinia to solid tumors with local hyperthermia. Hum. Gene Ther. (2005) 16:435-444.
   PubMed Web of Science ®Google Scholar
• ZINTCHENKO A, OGRIS M, WAGNER E: Temperature dependent gene expression induced by PNIPAM-based copolymers: potential of hyperthermia in gene transfer. Bioconjug. Chem. (2006) 17:766-772.
   PubMed Web of Science ®Google Scholar
• SELBO PK, HOGSET A, PRASMICKAITE L, BERG K: Photochemical internalisation: a novel drug delivery system. Tumour. Biol. (2002) 23:103-112.
   PubMed Web of Science ®Google Scholar
• HOGSET A, PRASMICKAITE L, SELBO PK et al.: Photochemical internalisation in drug and gene delivery. Adv. Drug Deliv. Rev. (2004) 56:95-115.
   PubMed Web of Science ®Google Scholar
• BERG K, DIETZE A, KAALHUS O, HOGSET A: Site-specific drug delivery by photochemical internalization enhances the antitumor effect of bleomycin. Clin. Cancer Res. (2005) 11:8476-8485.
   PubMed Web of Science ®Google Scholar
• HOGSET A, PRASMICKAITE L, ENGESAETER BO et al.: Light directed gene transfer by photochemical internalisation. Curr. Gene Ther. (2003) 3:89-112.
   PubMedGoogle Scholar
• PRASMICKAITE L, HOGSET A, TJELLE TE, OLSEN VM, BERG K: Role of endosomes in gene transfection mediated by photochemical internalisation (PCI). J. Gene Med.. (2000) 2:477-488.
   PubMed Web of Science ®Google Scholar
• KLOECKNER J, PRASMICKAITE L, HOGSET A, BERG K, WAGNER E: Photochemically enhanced gene delivery of EGF receptor-targeted DNA polyplexes. J. Drug Target. (2004) 12:205-213.
   PubMed Web of Science ®Google Scholar
• ENGESAETER BO, BONSTED A, BERG K et al.: PCI-enhanced adenoviral transduction employs the known uptake mechanism of adenoviral particles. Cancer Gene Ther. (2005) 12:439-448.
   PubMed Web of Science ®Google Scholar
• NDOYE A, DOLIVET G, HOGSET A et al.: Eradication of p53-mutated head and neck squamous cell carcinoma xenografts using nonviral p53 gene therapy and photochemical internalization. Mol. Ther. (2006) 13:1156-1162.
   PubMed Web of Science ®Google Scholar
• SHIR A, OGRIS M, WAGNER E, LEVITZKI A: EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice. PLoS Med. (2006) 3:e6.
   PubMed Web of Science ®Google Scholar